Sickle Cell Disease News and Research

Latest Sickle Cell Disease News and Research

Routine screening for SCD among refugees could help prevent life-threatening complications

Routine screening for SCD among refugees could help prevent life-threatening complications

New blood-cell analysis device helps better understand causes and mechanics of rare anemia

New blood-cell analysis device helps better understand causes and mechanics of rare anemia

UMN study shows impact of opioids on pain and survival in sickle cell disease

UMN study shows impact of opioids on pain and survival in sickle cell disease

Breakthrough study could lead to new treatments for sickle cell disease

Breakthrough study could lead to new treatments for sickle cell disease

Researchers develop new strategy to treat sickle cell disease and beta thalassemia

Researchers develop new strategy to treat sickle cell disease and beta thalassemia

Deadly inherited blood disorders cured with bone marrow transplant

Deadly inherited blood disorders cured with bone marrow transplant

Antibody-based treatment could improve cure rate for blood and immune disorders

Antibody-based treatment could improve cure rate for blood and immune disorders

Researcher studies how sickle cell disease affects blood flow and oxygen delivery

Researcher studies how sickle cell disease affects blood flow and oxygen delivery

New clinical practice guideline on home oxygen therapy for children

New clinical practice guideline on home oxygen therapy for children

African scientists to build research capacity in African countries, develop ongoing scientific partnerships

African scientists to build research capacity in African countries, develop ongoing scientific partnerships

New method modifies blood stem cells to reverse genetic mutation that causes IPEX

New method modifies blood stem cells to reverse genetic mutation that causes IPEX

New massive sequencing platform implemented for double factor preimplantation genetic testing

New massive sequencing platform implemented for double factor preimplantation genetic testing

Johns Hopkins researchers report challenges in treating severe crisis pain of sickle cell disease

Johns Hopkins researchers report challenges in treating severe crisis pain of sickle cell disease

FDA approves novel molecular-based assay to help determine blood compatibility

FDA approves novel molecular-based assay to help determine blood compatibility

Phase 2 results on tazemetostat EZH2 inhibitor to be presented at ESMO 2018

Phase 2 results on tazemetostat EZH2 inhibitor to be presented at ESMO 2018

FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials

FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials

Study sheds light on how vaso-occlusive pain crises arise in sickle-cell disease

Study sheds light on how vaso-occlusive pain crises arise in sickle-cell disease

Study reveals molecular mechanisms underlying expansive arterial remodeling

Study reveals molecular mechanisms underlying expansive arterial remodeling

NIH grant for Mount Sinai to study use of inhaled corticosteroids for treatment of sickle cell disease

NIH grant for Mount Sinai to study use of inhaled corticosteroids for treatment of sickle cell disease

Using CRISPR-Cas9 genome editing to correct mutation responsible for sickle cell disease

Using CRISPR-Cas9 genome editing to correct mutation responsible for sickle cell disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.